Hamilton Lane Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-96,474
| Closed | -$721K | – | 45 |
|
|
2023
Q2 | $721K | Hold |
96,474
| – | – | 0.32% | 36 |
|
|
2023
Q1 | $643K | Hold |
96,474
| – | – | 0.21% | 41 |
|
|
2022
Q4 | $744K | Buy |
96,474
+40,624
| +73% | +$313K | 0.27% | 40 |
|
|
2022
Q3 | $594K | Buy |
55,850
+40,625
| +267% | +$432K | 0.22% | 40 |
|
|
2022
Q2 | $124K | Hold |
15,225
| – | – | 0.05% | 66 |
|
|
2022
Q1 | $109K | Sell |
15,225
-11,898
| -44% | -$85.2K | 0.02% | 76 |
|
|
2021
Q4 | $465K | Buy |
+27,123
| New | +$465K | 0.06% | 70 |
|